Dr Krystyn Van Vliet on Using Engineered 3D Platforms to Identify Potential MS Drug Candidates
March 15th 2024Krystyn Van Vliet, PhD, vice president for research and innovation at Cornell University's Meinig School of Biomedical Engineering, discusses using engineered 3D platforms to identify potential multiple sclerosis (MS) drug candidates.
Watch
Dr Joshua Sabari Looks to the Future of Targeted Treatment for NSCLC
March 14th 2024March 1 saw the FDA grant full approval to amivantamab plus chemotherapy for first-line use in patients who have non–small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations, converting the May 2021 accelerated approval for this treatment in the second line.
Watch
Dr Jeff Stark: Pain Reduction With Bimekizumab-bkzx in Patients With HS
March 11th 2024Jeff Stark, MD, vice president and head of medical immunology, UCB, shares phase 3 study results of bimekizumab-bkzx given for up to 48 weeks in patients with moderate to severe hidradenitis suppurativa (HS).
Watch
Dr Jonathan Silverberg Discusses Findings on the Safety, Efficacy of Nemolizumab at 48 Weeks
March 10th 2024In patients with moderate to severe atopic dermatitis, nemolizumab demonstrated good durability of response, explained Jonathan Silverberg, MD, PhD, MPH, FAAD, of George Washington University School of Medicine and Health Sciences.
Watch
Dr Monica Li Discusses Tailoring Microneedling Treatments to Meet Each Patient's Need
March 10th 2024Monica Li, MD, medical and cosmetic dermatologist and clinical assistant professor, University of British Columbia, discusses how microneedling can address both aesthetic and medical dermatological needs across different skin types.
Watch
Dr Robert Sidbury: Understanding What Makes a Dermatology Practice Successful
March 9th 2024Robert Sidbury, MD, MPH, FAAD, division head of dermatology at Seattle Children's Hospital and professor of pediatrics at the University of Washington School of Medicine, discusses what makes a dermatology practice successful and the challenges that come with running a practice.
Watch
Dr Raj Chovatiya Outlines Who Is a Good Candidate for Oral JAK Inhibitors
March 8th 2024There are key factors to consider when selecting which patients with atopic dermatitis (AD) are suitable candidates for oral Janus kinase (JAK) inhibitors, explained Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School and founder and director of the Center for Medical Dermatology and Immunology Research.
Watch
Managing T1D During Pregnancy With Closed-Loop Insulin Delivery: Camilla Levister
March 8th 2024Camilla Levister, MS, ANP-C, CDCES, a nurse practitioner at the Icahn School of Medicine at Mount Sinai Hospital in New York, discusses how closed-loop artificial pancreas systems can help reduce the burden of type 1 diabetes (T1D) management during pregnancy.
Watch
Dr Xavier Montalban Discusses Phase 3 evolutionRMS Trial Designs, Outcomes
March 6th 2024While the results of evolutionRMS, comparing evobrutinib with teriflunomide, were negative, that "doesn't mean that evobrutinib is not working," said Xavier Montalban, MD, PhD, director of the Multiple Sclerosis Center of Catalonia (Cemcat).
Watch
Dr Joshua Sabari Discusses Amivantamab’s First-Line Approval for NSCLC
March 4th 2024The approval converts the May 2021 accelerated FDA approval for second-line treatment of non–small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations to a full approval in the first line following results from the phase 3 PAPILLON study.
Watch
Study Uses NIRS to Assess Hypoxia-Related Brain Function Impairment in Patients With MS
March 4th 2024Ateyeh Soroush, a PhD candidate at the University of Calgary, explains her ongoing study utilizing near-infrared spectroscopy (NIRS) to investigate hypoxia-related brain function impairment in patients with multiple sclerosis (MS).
Watch
Dr Ari Green Describes Remyelination Benefits for Patients With MS, Challenges of Trials
March 2nd 2024Ari Green, MD, of the University of California, San Francisco, details the benefits of remyelination for patients with multiple sclerosis (MS), as well as the challenges faced when conducting remyelination trials.
Watch
Dr Mitzi Joi Williams: Digital Tools Will Help Make MS Clinical Trials More Inclusive
March 2nd 2024Mitzi Joi Williams, MD, founder and medical director of Joi Life Wellness Multiple Sclerosis (MS) Center, explains the issue of underrepresentation in MS clinical trials and the potential for digital health technologies to help overcome this barrier.
Watch
Dr Jennifer Vaughn: Patients With MPN, MDS Should Discuss Long-Term Priorities Upfront
March 1st 2024For many patients with myeloproliferative neoplasms (MPNs) and myelodysplastic syndromes (MDS), their disease will be chronic, giving them a long-term cancer experience, said Jennifer Vaughn, MD, of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital.
Watch
Dr Stephen Speicher Navigates the Ethics of AI in Health Care
March 1st 2024Stephen Speicher, MD, Flatiron Health, highlights the organization's frameworks for ensuring ethical artificial intelligence (AI) usage, emphasizing the importance of providers and health systems asking critical questions when considering AI tools.
Watch
Cancer Care Plans Within ACOs Must Center Patients First: Dr Leslie Busby
February 29th 2024Leslie Busby, MD, chairman of the US Oncology Network Pharmacy & Therapeutics Committee, discusses the process of developing patient-centered care plans within the framework of an accountable care organization (ACO) and the importance of staying up to date with the latest best practices and therapies.
Watch
Getting to Know Dr Fabiola Molina, Hospitalist
February 26th 2024Fabiola Molina, MD, MHS, is a practicing hospitalist and assistant professor of medicine at Yale School of Medicine and Yale New Haven Hospital. An immigrant from Mexico, her experiences straddling 2 worlds, while attempting to navigate with her family the complicated safety-net system for health care in Texas, were key influences to her ardent focus on health equity.
Read More
Part 4: Dr James Robinson on the Impact of 340B Programs and Drug Pricing Policies
February 26th 2024In this final part of our interview with James Robinson, PhD, MPH, he underscores the need for employer education about the health plans they offer, fostering managed competition among hospital systems to drive down costs, and innovation in financing drug development.
Watch
The Promise of Frexalimab in MS Treatment: Part 1
February 26th 2024Patrick Vermersch, MD, PhD, joined The American Journal of Managed Care® for an interview on promising data from a phase 2 clinical trial on frexalimab in the treatment of multiple sclerosis (MS) and associated neurodegeneration.
Watch